In this episode, a roundtable of distinguished guests discuss the impact and challenges of polymorphism. You’ll hear from these life science and pharmaceutical experts:

• Eyal Barash, Life Sciences Patent Attorney and Founder at Barash Law

• Steve Byrn, Professor and Dept. Head at Purdue University

• Mansoor Khan, Professor and Vice Dean, Presidential Impact Fellow, Rangel College of Pharmacy, Texas A&M University

• Ken Morris, University Professor, Director Lachman Institute for Pharmaceutical Analysis, Long Island University

• Ann Newman, Solid-State and Pharmaceutical Consultant at Seventh Street Development Group

• Raj Suryanarayanan, Professor and WIlliam and Mildred Peters Endowed Chair at University of Minnesota

We talked about:

• The guests’ backgrounds and origin stories in life science

• The biggest challenges with respect to polymorphism

• Thinking in terms of practical benefit vs. the clinical benefit

• Distinguishing the formulation effect from the form effect

This episode is Part 1 of 2 on our polymorph roundtable discussion. Don’t miss the conclusion!

For more insights into the pharmaceutical industry, subscribe to the show on Apple Podcasts, Spotify, or wherever podcasts are found.

Listening on a desktop & can’t see the links? Just search for The Pharma Lab Show in your favorite podcast player.